2025-11-15 - Analysis Report
Okay, here's an analysis of Tempus AI Inc. (TEM) based on the data you provided.

## Tempus AI Inc. (TEM) Analysis

**Company Overview:** Tempus AI Inc. is a technology company focused on precision medicine through data and artificial intelligence.

### 1. Performance vs. S&P 500 (VOO)

*   **Cumulative Return:** TEM (35.99%) vs. VOO (27.75%)
*   **Spread:** 11.4%
*   **Relative Spread:** 45.2 (This indicates the current spread is in the middle range of its historical fluctuation relative to the S&P 500).
*   **Analysis of Provided Table:**

    | Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
    |------------|------|------|-------|------|-------|
    | 2023-2025  | 36.0% | 76.7% | 9.0% | 0.3 | 12.2 |

    *   **CAGR:** A Compound Annual Growth Rate of 36.0% shows strong growth potential.
    *   **MDD:** A Maximum Drawdown of 76.7% indicates high volatility and significant risk.
    *   **Alpha:** An Alpha of 9.0% suggests TEM has outperformed its benchmark (S&P 500) on a risk-adjusted basis.
    *   **Beta:** A Beta of 0.3 suggests TEM is significantly less volatile than the market as a whole.
    *   **Cap(B):** Market capitalization of $12.2 Billion

*   **In summary:** TEM has outperformed the S&P 500, but with significantly higher volatility.

### 2. Recent Price Action

*   **Current Price:** $68.48
*   **Last-market:** price increase by 0.79 from $67.94 to $68.48
*   **Moving Averages:**
    *   5-day MA: $70.17
    *   20-day MA: $81.80
    *   60-day MA: $83.69
*   **Analysis:** The stock price is currently below all three moving averages, suggesting a recent downtrend.

### 3. Technical Indicators and Outlook

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 14.04 (Oversold)
*   **PPO:** -2.52 (Bearish)
*   **Hybrid Signal:** cash_79%_Sell 79.9% of holdings (230 shares - Risky - MRI:0.50) (Cash Ratio: 79% on 2025-10-16)
*   **Recent Relative Spread Change (20-day):** 0.1 (+) (Short-term upward trend)
*   **Expected Return:** NaN (No expected return data available)
*   **Analysis:**
    *   The RSI indicates the stock may be oversold and could be due for a bounce.
    *   The PPO is negative, suggesting a bearish trend.
    *   The hybrid signal suggests selling 79.9% of holdings due to high risk with MRI of 0.5.
    *   The recent relative spread change indicates a short-term positive momentum compared to S&P 500.
    *   Recent price change from $67.94 to $68.48 indicates 급반등(sharp rebound)

### 4. Recent News & Events

*   **Positive News:**
    *   Tempus and IFLI Collaborate on Follicular Lymphoma Research
    *   Continued Strengthening of Genomics Leadership with New Products
    *   Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting
*   **Negative/Neutral News:**
    *   Losses Deepen, Profitability Still Elusive
    *   Volatility Equates to Opportunity (Mixed - suggests risk but potential upside)
*   **Irrelevant News:**
    *   Nancy Pelosi's Investment Returns (While interesting, not directly relevant to TEM's fundamentals)

### 4-2. Analyst Opinions

*   **Consensus:** Buy (Mean Rating: 2.23)
*   **Target Price:** Average $90.25 (Upside potential from current price)
*   **Analyst Sentiment:** Positive overall, with a Buy consensus.

### 5. Overall Analysis

Tempus AI (TEM) presents a mixed picture. On one hand, it has demonstrated strong growth and has outperformed the S&P 500 over the period examined, as reflected in its positive Alpha and CAGR. The company is also making strides in genomics, as highlighted by the news of new products and research collaborations.  Analyst consensus is positive, with a "Buy" rating and a target price significantly above the current level.

However, TEM exhibits high volatility, as evidenced by its substantial maximum drawdown. The negative PPO and "Sell" hybrid signal suggests potential further short-term downward pressure. The news also acknowledges that losses are deepening and profitability remains elusive, indicating potential financial concerns.

**In conclusion, TEM appears to be a high-risk, high-reward investment. It may be suitable for investors with a high-risk tolerance and a long-term investment horizon who are confident in the company's potential for future growth.** Investors should carefully consider the company's financial situation, the competitive landscape, and their own risk tolerance before investing in TEM. The oversold RSI suggests a potential short-term buying opportunity, but the overall bearish trend requires caution.
